Skip to main content
Log in

Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma

  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Based on encouragingin vitro andin vivo data, 14 consecutive patients with measurable metastatic previously untreated colorectal carcinoma were treated with a combination of intravenous etoposide and subcutaneous alpha-interferon. Etoposide was given at 60 mg/m2 intravenously on days 1–5 and alpha-interferon at 5 million units/m2 subcutaneously on days 1–5; courses were repeated every 21 days. All 14 patients were evaluable for response and toxicity. None of the patients achieved a complete or partial remission. Toxicity of this combination was moderate. Our data suggest that this combination is ineffective against colorectal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boring CC, Squires TS, Tong T. Cancer Statistics, 1992. Ca 42:19–38, 1992

    Google Scholar 

  2. Poon MA, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK, Levitt R, Kardinal CG, Mailliard JA. Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9:1967–1972, 1992

    Google Scholar 

  3. Von Hoff DD.In vitro data supporting interferon plus cytotoxic agent combinations. 18:58–61, 1991

    Google Scholar 

  4. Krigel RL, Slywotzky CM, Lonberg M, Green MD, Andes WA, Kempf R, Gupta S, Grace W, Spiegel RJ, Muggia FM, Grossberg H. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha-2b and etoposide. J Biol Resp Modif 7:359–364, 1988

    Google Scholar 

  5. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for therapy-induced toxicity. Cancer Invest 8:141–153, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ajani, J.A., Abbruzzese, J.L., Markowitz, A.B. et al. Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma. Invest New Drugs 11, 67–69 (1993). https://doi.org/10.1007/BF00873914

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00873914

Key words

Navigation